Telesis Bio Reports Fourth Quarter and Full Year 2023 Financial Results GlobeNewswire March 28, 2024 SAN DIEGO, March 28, 2024 (GLOBE NEWSWIRE) Telesis Bio Inc. (NASDAQ: TBIO), a leading provider of RNA and DNA solutions enabling researchers to accelerate therapeutic discovery through advanced, flexible, and rapid automated synthesis in their own.